Andrea Paola Rojas Gil

Prof. Dr. Andrea Paola Rojas Gil

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PZPanos G. Ziros
Panos G. Ziros
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
TGTassos Georgakopoulos
Tassos Georgakopoulos
IHIoannis Habeos
Ioannis Habeos
Dimitris KletsasDimitris Kletsas
Dimitris Kletsas
Athanasios G. PapavassiliouAthanasios G. Papavassiliou
Athanasios G. Papavassiliou
A primary goal of bone research is to understand the mechanism(s) by which mechanical forces dictate the cellular and metabolic activities of osteoblasts, the bone-forming cells. Several studies indicate that osteblastic cells respond to physical loading by transducing signals that alter gene expression patterns. Accumulated data have documented the fundamental role of the osteoblast-specific transcription factor Cbfa1 (core-binding factor) in osteoblast differentiation and function. Here, we demonstrate that low level mechanical deformation (stretching) of human osteoblastic cells directly up-regulates the expression and DNA binding activity of Cbfa1. This effect seems to be fine tuned by stretch-triggered induction of distinct mitogen-activated protein kinase cascades. Our novel finding that activated extracellular signal-regulated kinase mitogen-activated protein kinase physically interacts and phosphorylates endogenous Cbfa1 in vivo (ultimately potentiating this transcription factor) provides a molecular link between mechanostressing and stimulation of osteoblast differentiation. Elucidation of the specific modifiers and cofactors that operate in this mechanotranscription circuitry will contribute to a better understanding of mechanical load-induced bone formation which may set the basis for nonpharmacological intervention in bone loss pathologies.

14 March 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
Paraskevi DetopoulouParaskevi Detopoulou
Paraskevi Detopoulou
GPGeorgios Panoutsopoulos
Georgios Panoutsopoulos
MMMarina Mantoglou
Marina Mantoglou
PMPERIKLIS MICHAILIDIS
PERIKLIS MICHAILIDIS
IPIfigenia Pantazi
Ifigenia Pantazi
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
Inflammatory proteins activate platelets, which have been observed to be directly related to cancer progression and development. The aim of this systematic review is to investigate the possible association between Mean Platelet Volume (MPV) and cancer (diagnostic capacity of MPV, relation to survival, the severity of the disease, and metastasis). A literature review was performed in the online database PubMed and Google Scholar for the period of 2010–2022. In total, 83 studies including 21,034 participants with 12 different types of cancer (i.e., gastric cancer, colon cancer, esophageal squamous cell carcinoma, renal cancer, breast cancer, ovarian cancer, endometrial cancer, thyroid cancer, lung cancer, bladder cancer, gallbladder cancer, and multiple myeloma) were identified. The role of MPV has been extensively investigated in several types of cancer, such as gastric, colon, breast, and lung cancer, while few data exist for other types, such as renal, gallbladder cancer, and multiple myeloma. Most studies in gastric, breast, endometrium, thyroid, and lung cancer documented an elevated MPV in cancer patients. Data were less clear-cut for esophageal, ovarian, and colon cancer, while reduced MPV was observed in renal cell carcinoma and gallbladder cancer. Several studies on colon cancer (4 out of 6) and fewer on lung cancer (4 out of 10) indicated an unfavorable role of increased MPV regarding mortality. As far as other cancer types are concerned, fewer studies were conducted. MPV can be used as a potential biomarker in cancer diagnosis and could be a useful tool for the optimization of treatment strategies. Possible underlying mechanisms between cancer and MPV are discussed. However, further studies are needed to elucidate the exact role of MPV in cancer progression and metastasis.

30 September 2017
Verified
Book Chapter
Closed access
PDF file
PPParaskevi Patra
Paraskevi Patra
Victoria AlikariVictoria Alikari
Victoria Alikari
Evangelos FradelosEvangelos Fradelos
Evangelos Fradelos
ASAthanasios Sachlas
Athanasios Sachlas
MKMichael Kourakos
Michael Kourakos
SZSofia Zyga
Sofia Zyga

1 January 2009 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
ADA. Dettoraki
A. Dettoraki
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
BSBessie Spiliotis
Bessie Spiliotis
The binding of AGEs to RAGE is involved in diabetic vascular complications. We studied sRAGE levels and RAGE protein expression (P) together with N-carboxymethyl lysine (CML), a major AGE, in 74 patients with type 1 diabetes mellitus (DM1) and 43 healthy (C) children. sRAGE and CML levels were determined by ELISA and RAGE P was evaluated in mononuclear cells by Western immunoblotting. Serum sRAGE was higher in DM1 than in C (1430 +/- 759 vs 1158 +/- 595 pg/ml, p = 0.047), inversely correlated to diabetes duration (r = -0.265, p = 0.037) and directly correlated to LDL-cholesterol levels (r = 0.224, p = 0.039). Diabetes duration correlated independently with sRAGE (p = 0.034). Circulating CML levels were not significantly different between DM1 and C groups (3.51 +/- 1.49 vs 3.59 +/- 1.83 ng/ml, p > 0.05) and RAGE P was lower in DM1 than in C (61 +/- 46 vs 102 +/- 63%, p = 0.0001). Increased serum sRAGE in children with DM1 may provide temporary protection against cell damage and may be sufficient to eliminate excessive circulating CML.

30 September 2019 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MKMaria Efthymia Katsa
Maria Efthymia Katsa
AIAnastasios Ioannidis
Anastasios Ioannidis
ASAthanasios Sachlas
Athanasios Sachlas
IDIoannis Dimopoulos
Ioannis Dimopoulos
SCStylianos Chatzipanagiotou
Stylianos Chatzipanagiotou
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
To estimate the roles of triglyceride/high-density lipoprotein cholesterol (TG/HDL) ratio and uric acid in predisposition for metabolic syndrome (MetS) and its components in healthy children. Anthropometric and biochemical analyses were performed on 110 children, aged 5 to 12 years, from the Greek county of Laconia. The children were studied as a whole population and in separate groups according to age and predisposition to MetS after taking into consideration International Diabetes Federation criteria, body mass index, and lipid profile. Seventeen percent of children exhibited predisposition to MetS, while 39.1% had TG/HDL ratio >1, and 3.64% had high level of uric acid. According to a receiver operating characteristic curve analysis, the relative probability for MetS predisposition sextupled when TG/HDL ratio was ≥1 (odds ratio [OR], 5.986; 95% confidence interval [CI], 1.968-18.205). Children in the total population and those aged < 9 years had a greater probability for increased low-density lipoprotein (LDL) cholesterol (OR, 3.614; 95% CI, 1.561-8.365) when TG/HDL ratio was ≥ 1. The TG/HDL ratio was positively correlated with body mass index (BMI) (P=0.035) in children without MetS, cholesterol in the total population (P=0.06) and children ≥9 years old (P=0.026), and with LDL in the total population and both age groups (P=0.001). The TG/HDL ratio was also positively correlated with alanine aminotransferase in the total population (P=0.033) and gamma-glutamyl transferase in most studied groups (P<0.001). Uric acid was positively correlated with waist circumference in the total population (P=0.043) and in those without MetS (P=0.027). It was also positively correlated with BMI, TG, cholesterol, and TG/HDL ratio and negatively correlated with HDL in most studied groups (P<0.005). The studied parameters correlated with MetS components and could be characterized as effective indexes for childhood MetS, regardless of age and predisposition to MetS.

1 September 2019 in Hormones
Verified
Journal Article
Closed access
PDF file
RMRoza Mourelatou
Roza Mourelatou
Eirini KostopoulouEirini Kostopoulou
Eirini Kostopoulou
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
IKIoannis Kehagias
Ioannis Kehagias
DLDimitris Linos
Dimitris Linos
BSBessie Spiliotis
Bessie Spiliotis